Cannabis-related disorders and toxic effects

DA Gorelick - New England Journal of Medicine, 2023 - Mass Medical Soc
Cannabis-Related Disorders and Toxic Effects | NEJM Skip to main content NEJM Group
Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build …

Recommendations for reducing the risk of cannabis use-related adverse psychosis outcomes: a public mental health-oriented evidence review

B Fischer, W Hall, TM Fidalgo, E Hoch… - Journal of dual …, 2023 - Taylor & Francis
Objective: Cannabis use is increasingly normalized; psychosis is a major adverse health
outcome. We reviewed evidence on cannabis use-related risk factors for psychosis …

Association between cannabis use disorder and schizophrenia stronger in young males than in females

C Hjorthøj, W Compton, M Starzer… - Psychological …, 2023 - cambridge.org
BackgroundPrevious research suggests an increase in schizophrenia population
attributable risk fraction (PARF) for cannabis use disorder (CUD). However, sex and age …

Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis

DT Myran, M Pugliese, RL Roberts, M Solmi… - Molecular …, 2023 - nature.com
A major public health concern of cannabis legalization is that it may result in an increase in
psychotic disorders. We examined changes in emergency department (ED) visits for …

Adult use of highly-potent Δ9-THC cannabis concentrate products by US state cannabis legalization status, 2021

DS Hasin, J Borodovsky, D Shmulewitz, C Walsh… - Addictive …, 2023 - Elsevier
Background Compared to plant/flower cannabis products, cannabis concentrates have
higher average potency of delta-9-tetrahydrocannabinol (Δ9-THC), which may be …

Recreational cannabis legalization has had limited effects on a wide range of adult psychiatric and psychosocial outcomes

SM Zellers, JM Ross, GRB Saunders… - Psychological …, 2023 - cambridge.org
BackgroundThe causal impacts of recreational cannabis legalization are not well
understood due to the number of potential confounds. We sought to quantify possible causal …

How should policymakers regulate the tetrahydrocannabinol content of cannabis products in a legal market?

W Hall, J Leung, BH Carlini - Addiction, 2023 - Wiley Online Library
An increased use of high‐potency cannabis products since cannabis legalization in the
United States, Canada and elsewhere may increase cannabis‐related harm. Policymakers …

[HTML][HTML] On offer to Ontario consumers three years after legalization: A profile of cannabis products, cannabinoid content, plant type, and prices

F Tassone, P Di Ciano, Y Liu, S Rueda - Frontiers in Psychiatry, 2023 - frontiersin.org
Introduction Cannabis was legalized in Canada in October 2018, regulating the production,
distribution, sale, and possession of dried cannabis and cannabis oils. Additional products …

Old Dog, New Tricks: A Review of Identifying and Addressing Youth Cannabis Vaping in the Pediatric Clinical Setting

P Sharma, DB Mathews, QA Nguyen… - Clinical Medicine …, 2023 - journals.sagepub.com
Cannabis vaping has emerged as a predominant mode of cannabis use among United
States (US) adolescents and young adults (AYA) primarily due to the popularity of modifiable …

[HTML][HTML] The developmental trajectory to cannabis use disorder

JD Hinckley, JMN Ferland… - American Journal of …, 2024 - Am Psychiatric Assoc
The increase of cannabis use, particularly with the evolution of high potency products, and of
cannabis use disorder (CUD) are a growing health care concern. While the harms of adult …